Loss Executives Association

Novo Nordisk Must Face Shareholder Suit Over CagriSema Weight Loss Trial

July 29, 2026

A U.S. judge said on Tuesday that Novo Nordisk must face part of a lawsuit accusing it of defrauding shareholders about a clinical trial for its weight loss and diabetes treatment CagriSema. Novo Nordisk’s American depositary receipts fell 17.8% on …

Read the full article →

Share:

More Posts

Origin Says About 900,000 Customers’ Data Accessed in Breach

About 900,000 current and former Origin Energy Ltd. customers had their data accessed in a security breach, the latest in a string of cyberattacks on

Insurer Rewards Can Boost Climate Resilience Spending, Aon Says

Insurers can drive improvements in climate resilience by rewarding companies that invest to protect their businesses, rather than simply penalizing risky assets with higher premiums,

Instagram, Facebook Ran AI ‘Nudify’ Ads from China, NGO Says

Meta Platforms Inc.’s Facebook and Instagram have served thousands of ads for AI “nudify” apps in breach of the company’s policies, delivered by one of

Send Us A Message